Literature DB >> 31225835

Understanding Symptom Burden in Patients With Advanced Cancer Living in Rural Areas.

Stephanie Gilbertson-White1, Yelena Perkhounkova1, Seyedehtanaz Saeidzadeh1, Maria Hein1, Rachel Dahl1, Andrean Simons-Burnett1.   

Abstract

OBJECTIVES: To evaluate the feasibility of using a biobehavioral approach to examine symptom burden in rural residents with advanced cancer. SAMPLE &
SETTING: 21 patients with advanced lung, colorectal, or pancreatic cancer were enrolled at the University of Iowa in Iowa City. METHODS & VARIABLES: Using Cleeland's cytokine-immunologic model of symptom expression, symptom burden (i.e., severity, count, and interference) and inflammatory cytokines were measured for 24 weeks. Potential predictors included demographics, clinical characteristics, optimism, social support, and cancer-related stress. Descriptive statistics, Wilcoxon rank-sum, and Fisher's exact test were used for analysis.
RESULTS: Recruitment and retention rates were similar for rural and nonrural patients. Demographics, optimism, and social support were no different between groups. The cancer-related stress total score for rural patients was nearly half of the score of nonrural patients, with rural patients reporting significantly less avoidance. Symptom severity for the five worst symptoms remained moderate during the 24 weeks, whereas nonrural residents reported steady declines in severity of their five worst symptoms. Significant differences in inflammatory cytokines between groups were only found at one time point. IMPLICATIONS FOR NURSING: Rural residents who seek care at a cancer center may be clinically and demographically more similar to their nonrural counterparts than to rural residents seeking local care.

Entities:  

Keywords:  advanced cancer; isolation; rural; symptom burden; symptom management

Year:  2019        PMID: 31225835      PMCID: PMC6642634          DOI: 10.1188/19.ONF.428-441

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  56 in total

1.  Methodologic issues in the measurement of cytokines to elucidate the biological basis for cancer symptoms.

Authors:  Stephanie Gilbertson-White; Bradley E Aouizerat; Christine Miaskowski
Journal:  Biol Res Nurs       Date:  2010-08-26       Impact factor: 2.522

Review 2.  Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications.

Authors:  Julienne E Bower; Donald M Lamkin
Journal:  Brain Behav Immun       Date:  2012-07-06       Impact factor: 7.217

3.  Measuring the symptom burden associated with the treatment of chronic myeloid leukemia.

Authors:  Loretta A Williams; Araceli G Garcia Gonzalez; Patricia Ault; Tito R Mendoza; Mary L Sailors; Janet L Williams; Furong Huang; Aziz Nazha; Hagop M Kantarjian; Charles S Cleeland; Jorge E Cortes
Journal:  Blood       Date:  2013-06-18       Impact factor: 22.113

4.  Validation of interpersonal support evaluation list-12 (ISEL-12) scores among English- and Spanish-speaking Hispanics/Latinos from the HCHS/SOL Sociocultural Ancillary Study.

Authors:  Erin L Merz; Scott C Roesch; Vanessa L Malcarne; Frank J Penedo; Maria M Llabre; Orit B Weitzman; Elena L Navas-Nacher; Krista M Perreira; Franklyn Gonzalez; Liliana A Ponguta; Timothy P Johnson; Linda C Gallo
Journal:  Psychol Assess       Date:  2013-12-09

5.  The transition experience of rural older persons with advanced cancer and their families: a grounded theory study.

Authors:  Wendy D Duggleby; Kelly L Penz; Donna M Goodridge; Donna M Wilson; Beverly D Leipert; Patricia H Berry; Sylvia R Keall; Christopher J Justice
Journal:  BMC Palliat Care       Date:  2010-04-26       Impact factor: 3.234

6.  Stability of cytokines, chemokines and soluble activation markers in unprocessed blood stored under different conditions.

Authors:  Najib Aziz; Roger Detels; Joshua J Quint; Qian Li; David Gjertson; Anthony W Butch
Journal:  Cytokine       Date:  2016-05-18       Impact factor: 3.861

7.  Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation.

Authors:  Xin Shelley Wang; Qiuling Shi; Lori A Williams; Charles S Cleeland; Gary M Mobley; James M Reuben; Bang-Ning Lee; Sergio A Giralt
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.860

Review 8.  Cytokines and their relationship to the symptoms and outcome of cancer.

Authors:  Bostjan Seruga; Haibo Zhang; Lori J Bernstein; Ian F Tannock
Journal:  Nat Rev Cancer       Date:  2008-10-10       Impact factor: 60.716

9.  Disparities in mental health between rural and nonrural cancer survivors: a preliminary study.

Authors:  Jessica L Burris; Michael Andrykowski
Journal:  Psychooncology       Date:  2010-06       Impact factor: 3.894

10.  The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer.

Authors:  Ørnulf Paulsen; Barry Laird; Nina Aass; Tor Lea; Peter Fayers; Stein Kaasa; Pål Klepstad
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

View more
  6 in total

Review 1.  The efficacy of web or mobile-based interventions to alleviate emotional symptoms in people with advanced cancer: a systematic review and meta-analysis.

Authors:  Vijayvardhan Kamalumpundi; Seyedehtanaz Saeidzadeh; Nai-Ching Chi; Rajeshwari Nair; Stephanie Gilbertson-White
Journal:  Support Care Cancer       Date:  2021-11-04       Impact factor: 3.603

2.  Rural residence is related to shorter survival in epithelial ovarian cancer patients.

Authors:  Susan K Lutgendorf; Edgardo Ramirez; Andrew Schrepf; Mark C Valentine; Mary Charlton; M Bridget Zimmerman; Michael J Goodheart; Sharaf Zia; Anil K Sood; Premal H Thaker
Journal:  Gynecol Oncol       Date:  2021-08-13       Impact factor: 5.304

Review 3.  The Landscape of Connected Cancer Symptom Management in Rural America: A Narrative Review of Opportunities for Launching Connected Health Interventions.

Authors:  Ming-Yuan Chih; Anna McCowan; Sadie Whittaker; Melinda Krakow; David K Ahern; Eliah Aronoff-Spencer; Bradford W Hesse; Timothy W Mullett; Robin C Vanderpool
Journal:  J Appalach Health       Date:  2020-11-17

4.  Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma.

Authors:  Tingting Bian; Miaosen Zheng; Daishan Jiang; Jian Liu; Hui Sun; Xiaoli Li; Lei Liu; Jianguo Zhang; Yifei Liu
Journal:  Cancer Cell Int       Date:  2021-03-02       Impact factor: 5.722

5.  A Cross-Sectional Analysis of Ambulatory Oncology Experience by Treatment Intent.

Authors:  Linda Watson; Siwei Qi; Eclair Photitai; Andrea DeIure
Journal:  Curr Oncol       Date:  2020-12-18       Impact factor: 3.677

6.  Experiences of Patients After Withdrawal From Cancer Clinical Trials.

Authors:  Connie M Ulrich; Kathleen Knafl; Anessa M Foxwell; Qiuping Zhou; Cynthia Paidipati; Deborah Tiller; Sarah J Ratcliffe; Gwenyth R Wallen; Therese S Richmond; Mary Naylor; Thomas F Gordon; Christine Grady; Victoria Miller
Journal:  JAMA Netw Open       Date:  2021-08-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.